Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate |
2012-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2013-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EA-201201530-A1 |
titleOfInvention |
COMBINATION OF 4- {3- [CYC-HEXAGYDROCYCLOPENT [C] PYRROL-2- (1H) -IL] PROPOXY} BENZAMIDE AND NMDA-RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS, WHICH HAVE A VOLUME OF THE HYDROGECTOR AND THE ANTAGONIST |
abstract |
A combination of 4- {3- [cis-hexahydrocyclopenta [c] pyrrole-2 (1H) -yl] propoxy} benzamide of formula (I) or a pharmaceutically acceptable acid or base addition salt thereof and a glutamate NMDA receptor antagonist thereof. Medicines |
priorityDate |
2011-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |